Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Igenica Biotherapeutics Inc.

Latest From Novagali Pharma SA

Financings Of The Fortnight: Idenix To Forge Ahead On HCV Combo After Novartis’ Departure

Plus news on recent financial activity by Mersana Therapeutics, Hyperion Therapeutics, Atterocor and Exelixis.

BioPharmaceutical Business Strategies

Financings Of The Fortnight: Secondary Offerings Up From Pace Set In 2010 And 2011

Plus news on recent financings by Genkyotex, Synageva, Nektar Therapeutics and Edmond de Rothschild Investment Partners.

BioPharmaceutical Business Strategies

EdRIP raising €200M for new life sciences VC fund

Four years after closing the BioDiscovery 3 at €156 million, Edmond de Rothschild Investment Partners is now on the road raising a €200 million fourth fund to invest innovative European life sciences companies. The French venture capitalist started fundraising three weeks ago and is confident that it will be able to complete a first closing at more than €100 million by the end of April or early May.

Metabolic Disorders Gynecology & Urology

France's Adocia Completes 2012's First Euro Biotech IPO

French drug delivery company, Adocia, raises $33 million to develop new formulations of therapeutic proteins for wound healing, diabetes

BioPharmaceutical France
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Igenica Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Igenica Biotherapeutics Inc.
  • Senior Management
  • Hans van Houte, CFO
    Edward van der Horst, PhD, Sr. Dir., Preclin. Dev.
  • Contact Info
  • Igenica Biotherapeutics Inc.
    Phone: (650) 231-4320
    863A Mitten Rd.
    Ste. 100b2
    Burlingame, CA 94010